In three separate studies, IGF1R was shown to re-activate AKT/mTOR through interaction with either p110β25, the integrin alpha2/FAK complex42, or pyruvate dehydrogenase kinase (PDK1)43,44, in various cancers. This evidence concerns the gene PTK2 and cancer.